• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 UNK SHOULDER GLENOSPHERE DELTA XTEND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 UNK SHOULDER GLENOSPHERE DELTA XTEND Back to Search Results
Catalog Number UNK SHOULDER GLENOSPHERE DELTA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Unspecified Infection (1930)
Event Date 01/01/2022
Event Type  Injury  
Event Description
Literature article reviewed.Prithvi mohandas, md, rajsirish bellal sridharan, dnb, and senthilvelan rajagopalan.A retrospective analysis of complex proximal humerus fractures managed with reverse shoulder arthroplasty in a level 1 trauma center.Seminars in arthroplasty.01 jan 2022.The article's purpose was to analyze the long term results of these complex phf treated with reverse shoulder replacement.Patient data: 39 patients with a mean age of 63.18 years who were treated with rsa for acute complex fractures of the proximal humerus in our institution between 2013 and 2019.Depuy products: delta xtend.Please note, competitor implants were utilized in some patients in this study as well.Cement manufacturer is unknown.Adverse events ¿ please note, (n) indicates the number of occurrences is unknown.(1) periprosthetic infection ¿ treated with 2 stage revision.(1) periprosthetic infection with pain ¿ treated with iv antibiotics.(1) periprosthetic humerus fracture ¿ treated with cabling.(4) hematoma evacuation ¿ treated with surgical evacuation.(n) scapular notching ¿ treated conservatively.
 
Manufacturer Narrative
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.This complaint was opened to document complaints derived through a journal article review.Follow-ups were done to try and obtain additional information from the author of the journal article.No further information was received.Device history lot : a manufacturing record evaluation (mre), was not possible because the required lot code was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK SHOULDER GLENOSPHERE DELTA XTEND
Type of Device
SHOULDER GLENOSPHERE
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
Manufacturer (Section G)
DEPUY ORTHOPAEDICS, INC. 1818910
700 orthopaedic dr.
warsaw IN 46581 0988
Manufacturer Contact
kate karberg
700 orthpaedic dr.
warsaw, IN 46581
3035526892
MDR Report Key15138674
MDR Text Key296968878
Report Number1818910-2022-14600
Device Sequence Number1
Product Code HSD
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SHOULDER GLENOSPHERE DELTA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/23/2022
Initial Date FDA Received08/01/2022
Supplement Dates Manufacturer Received08/25/2022
Supplement Dates FDA Received08/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-